Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

20
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
20
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

98
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
98
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

11
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
11
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

167
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
167
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

197
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
197
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

194
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
194

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cohort-based assessment of drug use trends during the COVID-19 pandemic: relationship with mood and sociodemographic factors in Brazil.

Frontiers in psychiatry·2025
Same author

Situational Analysis of the Medication Practices in Brazilian Hospitals: A Multicenter Study.

Journal of patient safety·2025
Same author

The MetaGens algorithm for metagenomic database lossy compression and subject alignment.

Database : the journal of biological databases and curation·2023
Same author

Social distancing and changes in drug use: Results from a cross-sectional study during the COVID-19 pandemic in Brazil.

Frontiers in psychiatry·2022
Same author

Nurse Navigator: development of a program for Brazil.

Revista latino-americana de enfermagem·2020
Same author

Electronic prescription: frequency and severity of medication errors.

Revista da Associacao Medica Brasileira (1992)·2019

Related Experiment Video

Updated: Jul 13, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

5.8K

Impact of implementing a vancomycin protocol to reduce kidney toxicity: A comparative study.

Graziella Gasparotto Baiocco1, Stephanie Greiner2, Mário Borges Rosa3

  • 1Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.

Frontiers in Pharmacology
|October 16, 2023
PubMed
Summary

Implementing a vancomycin administration protocol significantly reduced acute kidney injury (AKI) rates in patients. This protocol ensured safer vancomycin dosing, minimizing nephrotoxicity and improving clinical outcomes.

Keywords:
acute kidney injurynephrotoxicitypatient safetyprotocolpublic healthvancomycin

More Related Videos

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.1K
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

7.3K

Related Experiment Videos

Last Updated: Jul 13, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

5.8K
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.1K
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

7.3K

Area of Science:

  • Pharmacology and Therapeutics
  • Nephrology
  • Infectious Diseases

Background:

  • Vancomycin is critical for treating Gram-positive infections but carries nephrotoxicity risks.
  • Effective vancomycin use requires careful administration and dose monitoring to balance efficacy and safety.
  • Understanding vancomycin's impact on clinical outcomes, including acute kidney injury (AKI), is essential.

Purpose of the Study:

  • To evaluate the incidence of AKI in patients receiving vancomycin before and after implementing an institutional protocol.
  • To assess the impact of a standardized vancomycin administration protocol on patient safety and clinical outcomes.

Main Methods:

  • A cross-sectional study analyzed electronic medical records of 422 patients receiving vancomycin.
  • Patients were divided into two cohorts: 2016 (pre-protocol) and 2018 (post-protocol).
  • Logistic regression and ROC curve analysis were used to predict AKI and assess model performance (AUC 0.764).

Main Results:

  • The post-protocol cohort (2018) showed a significant reduction in AKI incidence (20.9%) compared to the pre-protocol cohort (38.4%) (p < 0.001).
  • Post-protocol patients were older and had higher baseline creatinine, increased ICU admissions, and vasopressor use.
  • The logistic regression model demonstrated acceptable discrimination for predicting AKI.

Conclusions:

  • Implementation of the institutional vancomycin administration protocol significantly reduced AKI incidence.
  • The protocol ensured appropriate therapeutic dosing, leading to fewer adverse events like nephrotoxicity.
  • The protocol demonstrated a significant, cost-effective impact on improving patient clinical outcomes.